Clinical Trial Update: Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders [Phase 3]

View source ↗

Summary

Phase 3 placebo-controlled trial of valproate and risperidone in young children with bipolar disorder completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Valproate (valproate)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-10-20